Select Page

Ketamine’s promise for severe depression grows, but major questions remain

Ketamine’s promise for severe depression grows, but major questions remain

Using an old anesthesia drug to pull people out of the depths of severe depression has gone from fringe idea to widespread use in just a few years. But major questions remain about who ketamine can help, why some people get relief while others don’t, and the costs and benefits of different ways of delivering the drug. New findings just came out from a study that seeks to answer some of those questions.

About The Author

Michael Jannicelli

Michael Jannicelli - "A PROVEN BUSINESS FIRESTARTER & BRANDING GENIUS" a true natural born Trendsetter. • Created over 100 products under 3 brands, sold in 30+ countries worldwide and influencing youth across the globe. • Featured in Forbes magazine +over 100 print publications, television talk shows, major motion pictures and national radio stations. • Co-founder and VP of Bliss beverage USA and President/co-founder of Socko International - fastest growing privately held beverage company in US (Forbes) with Hogan Energy & Raw Energy WWE. • Co-founder of Throwdown Industries (2003) - leading brand in multibillion dollar Impact/Action Sports Market (products designed for superior MN • Diagnosed with auto-immune diseases aged 13; using his experience to help others and promote a positive message while developing edgy products to benefit people with chronic illness.

Recent Comments

No comments to show.

Subscribe

Subscribe To Our Giveaways !

Subscribe To Our Giveaways !

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!